Abstract: The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention also relates to the use of said hydrophobic peptide in a pharmaceutical as well as a food composition and methods of treating a mammal with said composition.
Type:
Grant
Filed:
December 23, 2013
Date of Patent:
May 10, 2016
Assignee:
Thylabisco AB
Inventors:
Per-Ake Albertsson, Charlotte Erlansson-Albertsson
Abstract: The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention also relates to the use of said hydrophobic peptide in a pharmaceutical as well as a food composition and methods of treating a mammal with said composition.
Type:
Grant
Filed:
December 23, 2013
Date of Patent:
November 17, 2015
Assignee:
Thylabisco AB
Inventors:
Per-Ake Albertsson, Charlotte Erlansson-Albertsson
Abstract: The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention also relates to the use of said hydrophobic peptide in a pharmaceutical as well as a food composition and methods of treating a mammal with said composition.
Type:
Application
Filed:
December 23, 2013
Publication date:
August 7, 2014
Applicant:
Thylabisco AB
Inventors:
Per-Ake ALBERTSSON, Charlotte ERLANSSON-ALBERTSSON
Abstract: The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention also relates to the use of said hydrophobic peptide in a pharmaceutical as well as a food composition and methods of treating a mammal with said composition.
Type:
Application
Filed:
December 23, 2013
Publication date:
August 7, 2014
Applicant:
Thylabisco AB
Inventors:
Per-Ake ALBERTSSON, Charlotte ERLANSSON-ALBERTSSON
Abstract: Disclosed, is a composition comprising thylakoids, or parts thereof, for reducing the transport of molecules through the intestinal mucosa of the intestinal tract of a mammal.
Type:
Application
Filed:
February 24, 2012
Publication date:
February 6, 2014
Applicant:
THYLABISCO AB
Inventors:
Charlotte Erlanson Albertsson, Per-Ake Albertsson
Abstract: The present invention relates to the use of a composition comprising at least one cell membrane fraction or parts thereof, for the reduction of lipolytic activity and/or to retard fat digestion, suppress appetite, body weight and/or lower blood lipids. The invention also relates to the use of said hydrophobic peptide in a pharmaceutical as well as a food composition and methods of treating a mammal with said composition.
Type:
Grant
Filed:
February 24, 2011
Date of Patent:
February 4, 2014
Assignee:
Thylabisco AB
Inventors:
Per-Åke Albertsson, Charlotte Albertsson-Erlanson